Nasopharyngeal Neoplasms - 25 Studies Found Completed : Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy : Nasopharyngeal Neoplasms : 2008-02-25 : Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen Completed : Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) : Nasopharyngeal Neoplasms : 2008-09-04 : Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni Not yet recruiting : Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2017-03-16 : Other: adverse events using patient-reported outcomes version of common term Recruiting : A Trial of Endostar in Patients With Carcinoma of the Head and Neck : Nasopharyngeal Neoplasms : 2016-08-12 : Drug: Endostar The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receiv Recruiting : Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122) : : 2024-09-07 Enrolling by invitation : A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2015-04-07 : Drug: endostar Other Name: Hum Completed : The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT : Nasopharyngeal Neoplasms : 2013-02-21 : Drug: Cisplatin induction: Cis Completed : Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer : Nasopharyngeal Neoplasms : 2007-12-18 : Procedure: Conventional Radiotherapy Proce Completed : Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2007-02-16 : Drug: Gemcitabine 1000mg/m Completed : Taxotere + Cisplatin in Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2007-02-16 : Drug: Docetaxel 75 mg/m² Next >>>